SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 4832.63 millions for the September 2021 quarter. The mentioned figure indicates a growth of about 36.22% as compared to Rs. 3547.63 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 216.98  millions from Rs. 255.76 millions ,decline by -15.16%.Operating profit for the quarter ended September 2021 rose to 914.88 millions as compared to 801.76 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 4832.63 3547.63 36.22 10038.78 6558.16 53.07 20326.20 16160.66 25.78
Other Income 119.32 380.36 -68.63 508.20 574.19 -11.49 969.06 1303.21 -25.64
PBIDT 914.88 801.76 14.11 2285.93 1355.78 68.61 4570.66 3476.50 31.47
Interest 3.48 5.97 -41.71 7.61 11.36 -33.01 19.90 17.67 12.62
PBDT 911.40 795.79 14.53 2278.32 1344.42 69.46 4550.76 3458.83 31.57
Depreciation 606.28 423.07 43.30 1145.37 777.56 47.30 1703.93 1370.79 24.30
PBT 305.12 372.72 -18.14 1132.95 566.86 99.86 2846.83 2088.04 36.34
TAX 88.14 116.96 -24.64 360.99 177.86 102.96 748.89 169.19 342.63
Deferred Tax 12.23 35.64 -65.68 84.00 53.83 56.05 235.31 -216.74 -208.57
PAT 216.98 255.76 -15.16 771.96 389.00 98.45 2097.94 1918.85 9.33
Equity 902.21 902.21 0.00 902.21 902.21 0.00 902.20 902.20 0.00
PBIDTM(%) 18.93 22.60 -16.23 22.77 20.67 10.15 22.49 21.51 4.53

Sharda Cropchem Share Price

1101.50 -8.20 (-0.74%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 656.15
PI Industries 3036.95
Bayer CropScience 4852.90
Sharda Cropchem 1101.50
Sumitomo Chemical 446.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×